SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001640455-19-000022
Filing Date
2019-03-06
Accepted
2019-03-06 11:18:44
Documents
6
Effectiveness Date
2019-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 jnce03072019s-8.htm S-8 83807
2 EXHIBIT 5.1 jnce03062019s-8exhibit51.htm EX-5.1 14452
3 EXHIBIT 23.2 jnce03092019s-8exhibit232.htm EX-23.2 2749
4 wha02.jpg GRAPHIC 18919
5 wha03.jpg GRAPHIC 18919
6 whfootera01.jpg GRAPHIC 186546
  Complete submission text file 0001640455-19-000022.txt   411313
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230088 | Film No.: 19661655
SIC: 2836 Biological Products, (No Diagnostic Substances)